Back
Cosmo Pharmaceuticals NV Quote, Financials, Valuation and Earnings
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
18
CMOPF
Cosmo Pharmaceuticals NV
Last Price:
69.62
Seasonality Move:
10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Cosmo Pharmaceuticals NV Price Quote
$69.62
Cosmo Pharmaceuticals NV Key Stats
Sell
18
Cosmo Pharmaceuticals NV (CMOPF)
is a Sell
Day range:
$69.62 - $69.62
52-week range:
$52.65 - $95.00
Dividend yield:
3.11%
P/E ratio:
0.00
P/S ratio:
5.62
P/B ratio:
2.09%
Volume:
0
Avg. volume:
1
1-year change:
42.81%
Market cap:
$1.1B
Revenue:
$100.4M
EPS:
$4.64
How Much Does Cosmo Pharmaceuticals NV Make?
-
How Much Are Cosmo Pharmaceuticals NV's Sales Annually?
CMOPF Revenues are $100.4M -
How Much Profit Does Cosmo Pharmaceuticals NV's Make A Year?
CMOPF net income is -$5.3M
Is Cosmo Pharmaceuticals NV Growing As A Company?
Data Unavailable
Cosmo Pharmaceuticals NV Stock Price Performance
-
Did Cosmo Pharmaceuticals NV Stock Go Up Last Month?
Cosmo Pharmaceuticals NV share price went down by -26.72% last month -
Did CMOPF's Share Price Rise Over The Last Year?
CMOPF share price rose by 42.81% over the past 1 year
What Is Cosmo Pharmaceuticals NV 52-Week High & Low?
-
What Is Cosmo Pharmaceuticals NV’s 52-Week High Share Price?
Cosmo Pharmaceuticals NV has traded as high as $95.00 over the past 52 weeks -
What Is Cosmo Pharmaceuticals NV’s 52-Week Low Share Price?
Cosmo Pharmaceuticals NV has traded as low as $52.65 over the past 52 weeks
Cosmo Pharmaceuticals NV Price To Free Cash Flow
-
Is Cosmo Pharmaceuticals NV Stock Overvalued?
Cosmo Pharmaceuticals NV is trading at a price to free cash flow ratio of 10.64 -
Is Cosmo Pharmaceuticals NV Stock Undervalued?
Cosmo Pharmaceuticals NV EV to Free Cash Flow ratio is 9.32 -
What Is Cosmo Pharmaceuticals NV’s Price Earnings Growth Ratio?
CMOPF PEG ratio is 0.17 -
Is Cosmo Pharmaceuticals NV Trading At A Premium To Earnings?
Cosmo Pharmaceuticals NV EV to EBIT ratio is 10.07
Is It Risky To Buy Cosmo Pharmaceuticals NV?
-
How Much Debt Does Cosmo Pharmaceuticals NV Have?
Total long term debt quarterly is $599.2K -
How Much Cash Does Cosmo Pharmaceuticals NV Have?
Cash and short term investments quarterly total is $143M -
What Is Cosmo Pharmaceuticals NV’s Book Value Per Share?
Book value per share is 33.30
Is Cosmo Pharmaceuticals NV Cash Flow Positive?
-
What Is CMOPF Cash Flow From Operations?
Cash flow from operations (TTM) is $126.3M -
What Is Cosmo Pharmaceuticals NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$204.2M -
What Is Cosmo Pharmaceuticals NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is $8.7M
Cosmo Pharmaceuticals NV Return On Invested Capital
-
Is Management Doing A Good Job?
CMOPF return on invested capital is 13.36% -
What Is Cosmo Pharmaceuticals NV Return On Assets?
ROA measures how assets are converting to revenues and is 10.72% -
What Is CMOPF Return On Equity?
ROE is a measure of profitability and is 15.06%
Cosmo Pharmaceuticals NV Earnings Date & Stock Price
-
What Is Cosmo Pharmaceuticals NV's Stock Price Today?
A single share of CMOPF can be purchased today for 69.62 -
What Is Cosmo Pharmaceuticals NV’s Stock Symbol?
Cosmo Pharmaceuticals NV trades on the otcm under the ticker symbol: CMOPF -
When Is Cosmo Pharmaceuticals NV’s Next Earnings Date?
The next quarterly earnings date for Cosmo Pharmaceuticals NV is scheduled on December 12, 2024 -
When Is CMOPF's next ex-dividend date?
Cosmo Pharmaceuticals NV's next ex-dividend date is July 10, 2024 -
How To Buy Cosmo Pharmaceuticals NV Stock?
You can buy Cosmo Pharmaceuticals NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cosmo Pharmaceuticals NV Competitors
-
Who Are Cosmo Pharmaceuticals NV's Competitors?
Below is a list of companies who compete with Cosmo Pharmaceuticals NV or are related in some way:
Cosmo Pharmaceuticals NV Dividend Yield
-
What Is CMOPF Dividend Yield?
Cosmo Pharmaceuticals NV’s dividend yield currently is 3.11% -
What Is Cosmo Pharmaceuticals NV’s Payout Ratio?
Cosmo Pharmaceuticals NV’s payout ratio is 6.07% -
When Did Cosmo Pharmaceuticals NV Last Pay A Dividend?
The latest dividend pay date is December 12, 2024 -
What Is Cosmo Pharmaceuticals NV’s Dividend Per Share?
Cosmo Pharmaceuticals NV pays a dividend of $0.00 per share
Cosmo Pharmaceuticals NV Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |